References

  1. Bens G, Maccari F, Estève E. Psoriasis: une maladie systémique. Presse Med. 2012; 41(4): 338-348. Google Scholar

  2. Gottlieb AB, Dann F. Comorbidities in patients with psoriasis. Am J Med. 2009 Dec;122(12):1150.e1-9. PubMed | Google Scholar

  3. Ammar-Khodja A, Benkaidali I, Bouadjar B, Serradj A, Titi A, Benchikhi H et al. EPIMAG: international cross-sectional epidemiological psoriasis study in the Maghreb. Dermatology. 2015; 231(2): 134-44. PubMed | Google Scholar

  4. Lee MS, Lin RY, Mei SL. Increased risk of diabetes mellitus in relation to the severity of psoriasis, concomitant medication and comorbidity: a nationwide population-based cohort study. J Am Acad Dermatol. 2014; 70(4): 691-698. PubMed | Google Scholar

  5. Picardi A, Pasquini P, Cattaruzza MS, Gaetano P, Baliva G, Melchi CF et al. Only limited support for a role of psychosomatic factors in psoriasis results from a case-control study. J psychosom Res. 2003; 55(3): 189-196. PubMed | Google Scholar

  6. Kerdel F, Zaiac M. An evolution in switching therapy for psoriasis patients who fail to meet treatment goals. Dermatol Ther. 2015; 28(6): 390-403. PubMed | Google Scholar

  7. Gulliver WP, Macdonald D, Gladney N, Alaghehbandan R, Rahman P, Adam Baker K. Long-term prognosis and comorbidities associated with psoriasis in the Newfoundland and Labrador founder population. J Cutan Med Surg. 2011; 15(1): 37-47. PubMed | Google Scholar

  8. Noori K, Breck T, Alan M. Comorbidities in psoriasis patients. Semin Cutan Med Surg. 2010; 29(1): 10-15. PubMed | Google Scholar

  9. Abdulghani M, Al Sheik A, Alkhawajah M, Ammoury A, Behrens F, Benchikhi H et al. Mnagement of psoriasis in Africa and the middle east: a review of current opinion, practice and opportunities for imptovement. J Int Med Res. 2011; 39(5): 1573-88. PubMed | Google Scholar

  10. Zhu KJ, He SM, Sun LD, Hu D, Cheng H, Zhang Z et al. Smoking and psoriasis: a Meta analysis of case-control studies. J DermatolSci. 2011; 63(2): 126-128. PubMed | Google Scholar

  11. Mebazza A, El Asmi M, ZidiW, Zayani Y, Cheikh Rouhou R, El Ounifi S et al. Metabolic syndrome in Tunisian psoriatic patients: Prevalence and determinants. J Eur Acad Dermatol Venereol. 2011; 25(6): 705-709. PubMed | Google Scholar

  12. O'Doherty CJ, McIntyre C. Palmoplantarpustulosis and smoking. Br Med J (Clin Res Ed). 1985 Sep 28;291(6499):861-4. PubMed | Google Scholar

  13. Setty AR, Gary C, Choi HK. Smoking and the risk of psoriasis in omen: Nurse's Health Study II. Am J Med. 2007; 120(11): 953-959. PubMed | Google Scholar

  14. Spah F. Inflammation in atherosclerosis and psoriasis commun pathogenic mechanisms and the potential for an integrated treatment approach. Br j Dermatol. 2008; 159(2): 10-17. PubMed | Google Scholar

  15. Frohm M, Agerberth B, Ahangari G, Stâhle-Bäckdahl M, Lidén S, Wigzell H et al. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem. 1997; 272(24): 15258-63. PubMed | Google Scholar

  16. Misery L. Depression et psoriasis. Ann Dermatol Venereol. 2012; 139 Suppl 2: S53-7. PubMed

  17. Takahashi H, Tsuji H, Takahashi I, Hashimoto Y, Ishida-Yamamoto A, Iizuka H. Prevalence of obesity/adiposity in Japanese psoriasis patients: adiposity is correlated with the severity of psoriasis». J DermatolSci. 2009; 55(1): 74-6. PubMed | Google Scholar

  18. Haslam DW, James WP. Obesity. Lancet. 2005 Oct 1;366(9492):1197-209. PubMed

  19. Herron MD, Hinckley M, Hoffman MS et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005; 141(12): 1527-1534. PubMed | Google Scholar

  20. Lan CC, Ko YC, Yu HS, Li WC, Lu YW, Yang YH et al. Psoriatic patients with diabetes are prone to develop digestive argon cancers: a population-based study in Taiwan. J Dermatol Sci. 2012; 68(2): 82-88. PubMed | Google Scholar

  21. Wang Y, Chen J, Zhao Y, Geng L, Song F, Chen HD. Psoriasis is associated with increased levels of serum leptin. Br J Dermatol. 2008; 158(5): 1134-5. PubMed | Google Scholar

  22. Shapiro J, Cohen AD, David M, Hodak E, Chodik G, Viner A et al. The association between psoriasis, diabetes mellitus and atherosclerosis in Israel: a case-control study. J Am AcadDermatol. 2007; 56(4): 629-634. PubMed | Google Scholar

  23. Kim CR, Lee JH. An observational Study on the obesity and metabolic status of psoriasis patients. Ann Dermatol Venereol. 2013; 25(4): 440-444. PubMed | Google Scholar

  24. Qureshi AA, Choi HK, Setty AR, Curhan GC. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol. 2009; 145(4): 379-382. PubMed | Google Scholar

  25. Fernandez-Real JM, Pickup JC. Innate immunity, insulin resistance and type 2 diabetes. Trends Endocrinol Metab. 2008; 19(1): 10-16. PubMed | Google Scholar

  26. Festa A, D'Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000; 102(1): 42-7. PubMed | Google Scholar

  27. Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueuredo A, Quintanilha A, Teixeira F. The inflammatory response inmildandinseverepsoriasis. Br J Dermatol. 2004; 150(5): 917-28. PubMed | Google Scholar

  28. Bowcock AM. Understanding the pathogenesis of psoriasis, psoriatic arthritis, and autoimmunity via a fusion of molecular genetics and immunology. Immunol Res. 2005;32(1-3):45-56. PubMed | Google Scholar

  29. Malbris L, Garanath F, Hamsten A, Strahle M. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol. 2006; 54(4): 614-621. PubMed | Google Scholar

  30. Wolkenstein P, Revuz J, Roujeau JC, Bonnelye G, Bastuji-Garin S. Psoriasis in France and associated risk factors: results of a case-control study based on a large community survey. Dermatology. 2009; 218(2): 103-9. PubMed | Google Scholar